Manchester and Liverpool founders can research regional equity funds, angel networks, science investors and selected national VC. These 10 provider families cover the North West without double-counting Praetura and Par Equity after their combination into PXN.
Use this list to build a focused research queue. Start with your company’s stage, the evidence you have and the milestone the round should finance. Then choose a small set of relevant providers, confirm the current mandate and plan an appropriate first conversation.
Manchester and Liverpool capital at a glance
This is a selective, unranked directory of 10 provider families. A venture fund, angel network, co-investor and growth or strategic investor can serve different company needs. The scope column records geographic, institutional or investment-stage context, not a claim that every organization is headquartered locally.
| Provider | Capital route | Investment scope |
|---|---|---|
| PXN Ventures | Multi-stage VC | North of England, Scotland and Northern Ireland |
| DSW Ventures | VC | Manchester and wider UK routes |
| Mercia Ventures | VC | UK-wide; strong regional presence |
| Foresight regional investment funds | Regional growth-equity investor | North West and selected neighbouring regions |
| GC Angels | Publicly backed early-stage co-investor | Greater Manchester and wider North West |
| NorthInvest | Angel investment network | Northern technology startups |
| Northern Gritstone | Science and technology investor | North of England |
| SFC Capital | Early-stage investor | UK-wide |
| Ascension | Pre-seed and seed VC | London-based; wider UK and international mandates |
| LYVA Labs | Pre-seed investor and innovation platform | Liverpool City Region |
Check the region, the vehicle and the investment stage
- A Northern brand does not mean every vehicle covers every North West postcode.
- Separate first-capital and science-commercialisation routes from Series A scaling capital.
- Check whether a manager is accepting new investments or only supporting an existing portfolio.
Illustrative example: a Liverpool science-based startup researches LYVA’s regional route, an appropriate Northern science investor and relevant seed networks. It documents the company’s regional connection and technical milestone. A Series A-focused fund is a later relationship, and legacy merged brands do not become duplicate outreach targets.
Avoid this shortcut: Praetura and Par Equity are one current provider family under PXN. River Capital’s existing equity-portfolio continuity announcement is not treated here as proof of a new founder-facing VC allocation.
10 providers to research
1. PXN Ventures
Multi-stage VC. North of England, Scotland and Northern Ireland.
Praetura Ventures and Par Equity have combined under PXN, which describes pre-seed-to-Series-B-plus support for Northern companies. PXN Ventures official information.
Prepare before outreach: Count the combined firm once. Use the current team and fund route, not two duplicate legacy entries.
2. DSW Ventures
VC. Manchester and wider UK routes.
DSW maintains a Manchester venture-capital location page and a founder-facing investment route. DSW Ventures official information.
Prepare before outreach: Check the current fund criteria and partner fit directly. A local office alone does not establish sector or stage eligibility.
3. Mercia Ventures
VC. UK-wide; strong regional presence.
Mercia Ventures’ current site describes Series A-and-beyond investing in companies with early traction and a route to scale. Mercia Ventures official information.
Prepare before outreach: Use the current venture strategy, rather than assuming every historical Mercia seed or regional vehicle has the same mandate.
4. Foresight regional investment funds
Regional growth-equity investor. North West and selected neighbouring regions.
Foresight’s Manchester team supports regional growth companies. Its North West page distinguishes a fund now in realisation from newer regional growth-equity vehicles. Foresight regional investment funds official information.
Prepare before outreach: Choose the live vehicle and demonstrate an operating growth business. This is not an idea-stage angel route or evidence that a legacy fund is making new investments.
5. GC Angels
Publicly backed early-stage co-investor. Greater Manchester and wider North West.
GC Angels invests directly alongside angels and institutional capital in early-stage companies across Greater Manchester and the wider North West. GC Angels official information.
Prepare before outreach: Prepare the company’s regional connection and potential co-investment plan, then confirm the live criteria.
6. NorthInvest
Angel investment network. Northern technology startups.
NorthInvest connects early-stage Northern technology businesses with angel and institutional investment networks. NorthInvest official information.
Prepare before outreach: Use the fundraising and eligibility route. An introduction network is not one discretionary venture fund.
7. Northern Gritstone
Science and technology investor. North of England.
Northern Gritstone backs IP-rich science and technology businesses with global ambition, with a focus on deep tech and life sciences. Northern Gritstone official information.
Prepare before outreach: Substantiate the regional research and company connection and the proof needed to move toward commercial scale.
8. SFC Capital
Early-stage investor. UK-wide.
SFC provides early-stage company investment routes across the UK, beyond a single city ecosystem. SFC Capital official information.
Prepare before outreach: Confirm current company and fund criteria with the investment team and qualified advisers. Do not treat tax-product eligibility as a self-assessment exercise.
9. Ascension
Pre-seed and seed VC. London-based; wider UK and international mandates.
Ascension invests through generalist and thesis-driven funds at pre-seed and seed. Ascension official information.
Prepare before outreach: Choose a relevant vehicle and business-model fit. It is a national alternative, not a Manchester-headquartered firm.
10. LYVA Labs
Pre-seed investor and innovation platform. Liverpool City Region.
LYVA Labs provides pre-seed investment and support for innovative health, life-science, deep-tech and clean-tech businesses in Liverpool City Region. LYVA Labs official information.
Prepare before outreach: Distinguish startup equity from its separate SME support or grant programs, and verify the regional connection.
Turn the directory into your next five research actions
Choose five providers with a plausible mandate match, not five familiar logos. For each one, keep a source and one unresolved fit question beside the next action. Leave unknown information blank until you can verify it.
A compact investor-fit worksheet
Copy one record per provider. Replace the bracketed fields with company-specific evidence.
Manchester and Liverpool investor research
Provider: [name and specific fund]
Official source + checked date: [URL, date]
Why our stage and technology fit: [evidence]
Geographic or institutional connection: [evidence]
Milestone this round finances: [specific result]
Open fit question: [one question]
Introduction or founder route: [verified route]
Owner + next action + date: [person, action, date]
Decision: [research next / ask a question / hold]Move a provider forward when the current mandate and your company evidence match. Ask a question when one material criterion is unclear. Hold when the fund is at the wrong stage, serves a different company geography or expects evidence you do not yet have. Do not treat a contact record as investor interest.
Give Aurora, Claude or Codex a focused research mission
Use this prompt with Aurora in Finta, Claude or Codex. Add only material you are authorized to share. Review the result before adding records or contacting anyone.
Be my Manchester and Liverpool investor-research teammate.
Company: [one sentence, stage and location]
Technology or business model: [specific scope]
Evidence we have: [authorized facts only]
Next financing milestone: [result to fund]
Candidates: [paste five provider names from this guide]
Check each provider's current official sources.
Return: fit evidence, source URL/date, one open question, next action.
Separate local presence, investment reach and eligibility.
Mark missing facts unknown; do not invent cheque sizes or contacts.
Check portfolio conflicts before suggesting sensitive material.
Draft a research queue only. Do not contact or submit to anyone.Keep the next step moving
A useful shortlist connects investor fit to a relationship owner and a specific next action. Use Finta’s investor-prospecting workflow to organize the research. Keep the official source, contact context and follow-up together in your fundraising pipeline.
Before asking for an introduction, review portfolio conflicts and prepare a relevant message. The warm-introduction guide explains how to make a clear, permission-aware request. A possible path is not a completed introduction or a financing commitment.
A common founder question
Is this a list of Manchester-headquartered funds only?
No. It covers Manchester, Liverpool and North West routes, plus clearly labelled national alternatives. Location and vehicle-specific investment criteria are separate checks.
How this list was researched
Research reviewed on October 28, 2026 using the linked official investment, portfolio and program pages. We count related firms and vehicles as one provider family where noted. Order is not a performance ranking. Public mandate evidence does not establish uncommitted capital, an open application window or an offer to invest; confirm the current process directly. The cover is an illustrative ecosystem, not a literal map or an investor-network diagram.
Authored by Finta Editorial Team. Source review was AI-assisted; hypothetical examples are labelled illustrative and are not customer results.
Informational guidance
This content is for general informational and educational purposes, not personalized investment, financial, legal or tax advice. Finta is not a law firm. Consult your attorney or accountant about financing documents, eligibility, intellectual property, tax treatment and your company’s circumstances.